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Summary: Lactoferrin was analysed with an ELISA in pleural effusions from 21 patients with malignant exudative
effusions (15 carcinomas and 6 mesotheliomas), 12 patients with non-malignant exudative effusions of unknown
aetiology, 11 patients with transudative effusions due to congestive heart failure, 12 patients with exudative effusions
secondary to infection, and 2 patients with tuberculous effusions. Mediän pleural fluid lactoferrin was 133 g/l
(ränge 25-435) in carcinomas, 55 g/l (23-185) in mesotheliomas, 198 g/l (31-530) in non-malignant exudates,
68 g/l (17-205) in transudates, 1815 g/l (1380-2050) in infectious exudates and 107 g/l (88-125) in tubercu-
losis. Due to a wide overlap between the various groups pleural fluid lactoferrin appears to be of limited value in
the routine diagnostic evaluation of non-infectious pleural effusions, but seems to separate infectious exudates from
non-infectious exudates.
Introduction
Lactoferrin is an iron-bindhig glycoprotein which is
very similar in structure to transferrin (1). Lactoferrin is
present in the specific granules of neutrophilic granulo-
cytes (2), plasma (3), milk (4) and various other secre-
tions (5). Eleväted conceritrations of lactoferrin has been
found to be indicative of inflammation in several clinical
conditions (6—8).
The most frequently examined pathological effiision is
probably pleurai fluid, in which lactoferrin has not pre^
viously been investigated. Considering that lactoferrin
has been found in bronchial mücus (9) and lung cancer
extracts (10) it is possible that the level of lactoferrin in
pleural fluid may be of diagnostic value. Especially high
values could be expected in effusions secondary to bac-
terial infections, but not in effusions secondary to viral
infections, since the neutrophil content of lactoferrin has
been shown to be decreased in viral infections (11). The
purpose of the present study was to demonstrate lacto-
ferrin in pleural fluid and to assess the value of lactofer-
rin in the differential diagnosis of pleural fluids of vari-
ous origins.
Patients and Methods
The study comprised 58 patients (21 females, 37 males) with a
median age of 68 years (ränge 27—87), in whom a diagnostic
thoracoceritesis was performed. The final diägnoses were decided
after observing the clinical course of the patients in a follow-up
period after entry into the study (12—24 months), and after diag-
nostic procedures including cytological examination and culture of
pleural fluid for bacteria including mycobacteria (but not for
viruses), and Kistological examination of pleural biopsy specimens
obtained by thoracoscopy or at autopsy. The patients were divided
into six diagnostic groups.
Group 7, carcinomatous exudates
Fifteen patients had malignant disease with pleural invasion (11
pulmoriary carcinomas and 4 extrapulmonary carcinomas with
pleural metastases).
Group 2, mesothelioma exudates
Six patients had malignant mesothelioma.
Group 3, idiopathic exudates
Twelve patients without congestive heart failure or any other obvi-
ous caüse of pleurisy were classified äs having pleural effusions of
unknown aetiology.
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Group 4, hearlfailure transudates
Eleven patients with congestive heart failure and pleural effusions
responding to diuretic treatment, who did not have any other obvi-
ous cause of pleurisy, were classified s having transudates.
Group 5, infectious exudates
Twelve patients with pleural exudates secondary to pulmonary in-
fection. Six patients had fever, a pulmonary Infiltrate and clear or
turbid yellow pleural fluid, all of which disappeared after antibiotic
treatment, and 6 patients had empyema which disappeared after
antibiotic treatment and intermittent thoracocentesis. Pathogenic
bacteria were found in 8 cases (Streptococci 4, Staphylococcus
aureus 2, Haemophilus 2). In 4 cases treated with antibiotics at the
time of cultivation no bacteria were found.
Results
Figure l shows the concentrations of lactoferrin in the
subgroups. Pleural fluid lactoferrin is mueh higher in the
infectious group than in the other groups (p < 0.0001).
Among the 12 infectious patients there was no differ-
ence between thpse with clear or turbid yellow fluid and
those with empyema. The other groups did not differ
significantly from e ch other. Figure 2 shows the con-
centrations of protein in the subgroups. As expected the
level of protein in transudates differ significantly from
the level of protein in exudates (p < 0.0001). The exu-
date groups, however, do not differ from each other. The
Group 6, tubercidous exudates
Two patients had a positive culture of M tuberculosis in the pleu-
ral fluid.
Sampling» ,
Pleural fluid was collected in heparin coated glass tubes and centri-
fuged within one hour. The pleural fluid was then at once deep
frozen and kept at — 18 °C until use.
The number of neutrophils was estimated arbitrarily in three groups
(none (0), moderate (H-, ++), many (+ + +) by a pathologist.
The following analyses were performed on centrifuged pleural
fluid: Protein by the biuret reaction (12) and lactoferrin by an
ELISA method. The ELISA method has been described in detail
previously (13).
Assay of lactoferrin
One-hundred μΐ of prediluted lactoferrin antiserum (DAKO Immu-
noglobulins Ltd., Copenhagen, Denmark) was pipetted into each
well of a microtitration plate and left overnight at rooin temper -
ture. The following day the wells were emptied by inversiofi and
tapped dry on absorbent paper. The plate was then washed three
times with wash buffer. Lactoferrin Standard (Behringwerke AG-
Marburg, Germany) or 100 μΐ of test samples diluted l : 100 with
dilution solution were applied s duplicates in the wells of the
microtitration plate and incubation at room temperature. The wells
were emptied after 60 min and washed three times with wash
buffer. One-hundred μΐ of prediluted anti4iuman lactoferrin
(DAKO Immunoglobulins Ltd., Copenhagen, Denmark) was then
pipetted into each well and left for 60 min at room temperature.
The wash procedure was repeated and 100 μΐ of a colour reagent
applied to each well. The reaction was now allowed to proceed for
15 min, before being stopped by the addition of 200 μΐ of sulphuric
acid. The extinction of the Contents of each well was measured in
a Titertec Multiscan MC (Flow Laboratories) at 488 nm. A dose-
response curve was plotted on semilogarithmic paper. At lactoferrin
concentrations between 25 μg/l and 345 μg/l the intra-assay coeffi-
cient of Variation varied between 2% and 4% and the inter-assay
coefficient of Variation varied between 3% and 14%, being highest
at the lower concentrations.
Statistical analysis
Due to sample size the results of group 6 were not analysed statis-
tically. Differences between groups were evaluated by the Kruskal-
Wallis test and Wilcoxons test for unpaired differences.
l
l
0|
G
"8
JE
zuw
1800·
1600;
1400-
1200·
1000;
800·
600;
400·
Ο- I i I , :
Ι 2 3 4 5
Diagnos c groups
Fig. l The concentration of pleural fluid lactoferrin (mean, l
Standard deviation) in the subgroups.
Group 1: carcinomatous exudates:
Groiip 2: mesothelioma exudates;
Group 3: idiopathic exudates;
Group 4: heart failure transudates;
Group 5: infectious exudates.
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Fig. 2 The concentration of pleural fluid protein (mean, l stan=-
dard deviation) in the subgroups.
Group 1: carcinomatous exudates;
Group 2: mesothelioma exudates;
Group 3: idiopathic exudates;
Group 4: heart failure transduates; *
Group 5: infectious exudates. * >
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Tab. l Pieural fluid analyses in patients with effusions of malig·
nant, benign and infectious origin, and in transudates and non-
infectious exudates; median (ränge).
Pleural
effiision
Malignant
(N = 21)
P
Benign
(N = 23)
P
Infectious
(N = 12)
P
Exudate
(N = 33)
P
Transudate
(N =11)
Group
1 + 2
3 + 4
5
1 + 2 + 3
4
Lactoferrin
( §/0
89 (23-435)
NS
95 (17-530)
0.0001
1815(1380-2050)
0.0001
150(23-530)
0.04
68(17-205)
Protein
(g/0
42 (24-53)
0.03
32(11-50)
0.0001
47 (38-59)
NS
44 (24-53)
0.0001
22(11-30)
levels of lactoferrin in malignant and benign effusions
were almost identical (tab. 1). Pleural fluid lactoferrin is
significantly higher in exudates than in transudates (tab.
1). The pattern of differences between groups is similar
\ to that of pleural fluid protein, although less significant
| (tab. 1). Figure 3 shows that the level of lactoferrin is
i higher in the group with many neutrophils than in the
groups with none or a moderate number of neutrophils
(p < 0.0001). There were many neutrophils in all 12 ex-
udates from the infectious group. In the other patient
groups there were either none or a moderate number of
neutrophils. The concentration of pleural fluid protein
was not diffefent in the three groups.
Pleural fluid lactoferriri in the two patients with tubercu-
losis was 88 g/l and 125 g/l, respectively.
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Fig. 3 The concentration of pleural fluid lactoferrin (mean, l
Standard deviation) according to number of pleural fluid neutro-
phils.
Discussion
The present results indicate that lactoferrin completely
separates infectious effusions of probable bacterial ori-
gin (with the exception of tuberculosis) from non-bacte-
rial effusions. Lactoferrin cannot be used to distinguish
between malignant and non-malignant effusions (tab. 1).
The significant differences between the group of patients
with transudates and the group with exudates seem clini-
cally unimportant, due to considerable overlap between
the groups (tab. 1), except that values > 200 g/l were
found almost exclusively in idiopathic and carcinoma-
tous exudates, and not in heart failure transudates or
mesothelioma exudates. This is probably explained by
the fact that neutrophilic granulocytes were present in
more than 50% of idiopathic and carcinomatous exu-
dates but in less than 20% of transudates and mesotheli-
oma exudates, in accordance with the positive relation
found between pleural fluid neutrophils and pleural fluid
lactoferrin (flg. 3). The high lactoferrin level in bacterial
effusions is also due to a high number of neutrophils. A
positive correlation between the number of neutrophils
and the level of lactoferrin has been found in cerebrospi-
nal fluid (6) and synovial fluid (7), reflecting the fact
that lactoferrin is produced in the granules of the neutro-
phils. In another study Rosenmund et al. found that the
plasma lactoferrin/neutrophil ratio was relatively con-
stant in conditions with a high lactoferrin level such äs
cirrhosis of the liver and septicaemia, äs well äs in con-
ditions with a low level of lactoferrin such äs tumours,
iron deficiency and hepatitis B, strongly indicating that
the lactoferrin level depends mainly on the neutrophil
count (14).
There were many neutrophils in all 12 exudates from
the infectious group, but only 6 of these were purulent
(empyema). Pus contains not only intact neutrophils, but
also liquefied necrotic material and disintegrated neutro-
phils, which contributes to the white creamy appearance
of empyema. The non-purulent parapneumonic effusions
may be clear or turbid, depending on the number of neu-
trophils. Such effusioris cannot macroscopically be dis-
tinguished from pleural effusions of non-infectious ori-
gin. Normally the non-purulent effusions are uncompli-
cated and disappear after antibiotic treatment, whereas
empyemas are complicated and need drainage (15).
Since we found no difference in lactoferrin in these two
subgroups, this may indicate that the number of neutro-
phils in the two groups was the same, or that the neutro-
phil content of lactoferrin was different. Since we did
not measure the specific number of neutrophils, we are
not able to elucidate this problem further. The median
level of lactoferrin in non-bacterial pleural fluid (92
g/l) (ränge 17-530) is relatively low compared with
that found in synovial fluid in patients with os-
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teoarthrosis (970 g/l ± 390, mean ± SEM) (7) and
normal plasma (median 395 §/1, ränge 190-810) (8),
but higher than in normal cerebrospinal fluid (7.3 g/l
± 4.7, mean ± SEM) (6). Probably lactoferrin in pleural
fluid originates entirely from neutrophils and/or plasma,
and not from the pleura itself. The level of lactoferrin in
pleural exudate due to bacterial infection in the present
study was higher than found in cerebrospinal fluid from
patients with meningitis (360 g/l ± 168, mean ± SEM)
(6), but not äs high äs found in synovial fluid from pa^
tients with septic arthritis (127000 g/l ± 46 100, mean
± SEM) (7). The relatively low level of laetoferrin
found in tuberculous pleural fluids corresponds well
with the fact that the tuberculous inflammation consists
mainly of mononuclear cells and lymphocytes and not
of neutrophils.
In conclusion, this study has shown that lactoferrin is
present in pleural effusions. The value of lactoferrin in
the differentiation between pleural effiisions of non in-
fectious and of kfectious origin seems high. Although
values higher than 200 §/1 are rare in transudates and
exudates from mesotheliomas, lactoferrin is of limited
value in the differentiation between non-infectious pleu^·
ral effusions of different origm! Protein is still the best
discriminator between transudates and exudates, but
none of the investigated variables could be used to dif-
ferentiate between exudates of non-infectious origin. In
our investigation we measured lactoferrin in empyemas
for comparison. In clinical practice it shall not be neces^
sary to measure lactoferrin in purulent effusions, since
these almost always are complicated paräprieumonic
empyemas. The main result of our investigatipns is that
a clear or turbid yellow fluid with a high level of lacto-
ferrin is probably of bacterial origin, whereas one with
a low level of lactoferrin is probably non-bacterial.
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